Clinical trial
Objective Markers and New Indicators in Adrenal Insufficiency Disease (OMNI-AID Study)
NCT03615859 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Objective Markers and New Indicators in Adrenal Insufficiency Disease (OMNI-AID Study)
- Lead sponsor
- Imperial College London
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 1, 2018
- Completion date
- April 2, 2021
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.